Legacy Private Trust’s ARK Genomic Revolution ETF ARKG Stock Holding History

Legacy Private Trust’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-13,655	Closed	-$836K	–	237
2021 Q4	$836K	Sell	13,655 -3,669	-21%	-$254K	0.06%	162
2021 Q3	$1.29M	Sell	17,324 -478	-3%	-$40.1K	0.1%	131
2021 Q2	$1.65M	Buy	17,802 +4,658	+35%	+$396K	0.14%	121
2021 Q1	$1.17M	Buy	13,144 +98	+0.8%	+$9.72K	0.11%	130
2020 Q4	$1.22M	Sell	13,046 -268	-2%	-$21.4K	0.12%	121
2020 Q3	$848K	Buy	13,314 +241	+2%	+$14.1K	0.09%	136
2020 Q2	$682K	Buy	+13,073	New	+$561K	0.08%	136

Other funds holding ARKG

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Legacy Private Trust's ARKG Position: Q1 2022 in Review

Legacy Private Trust sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2022, closing a stake of 13,655 shares — an estimated $836K sold.

Legacy Private Trust first reported a position in ARKG in Q2 2020 and held it in 7 quarters. The position peaked at $1.65M in Q2 2021. 388 funds tracked by Wall St. Rank hold ARKG as of Q1 2022.

Legacy Private Trust reported no remaining ARK Genomic Revolution ETF position as of Q1 2022 after selling out during the quarter.
Legacy Private Trust sold 13,655 ARK Genomic Revolution ETF shares in Q1 2022, an estimated $836K.
Legacy Private Trust first reported a position in ARK Genomic Revolution ETF in Q2 2020 and held it in 7 quarters.
Legacy Private Trust's ARK Genomic Revolution ETF position peaked at $1.65M in Q2 2021.
388 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2022.

Based on Legacy Private Trust's 13F filing for Q1 2022, filed 11 Apr 2022.